Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome

NCT03794492 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Mycophenolate mofetil 500mg Tab. or 250mg Cap.
DRUG: Tacrolimus
DRUG: Methylprednisolone/prednisolone
DRUG: Basiliximab

Sponsor

Chong Kun Dang Pharmaceutical